Cargando…

Editorial: Advances in drug discovery for anti-Alzheimer’s agents

Detalles Bibliográficos
Autor principal:	Ismaili, Lhassane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540192/ https://www.ncbi.nlm.nih.gov/pubmed/36212059 http://dx.doi.org/10.3389/fchem.2022.1028829

Ejemplares similares

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

Editorial: Computational Approaches in Drug Discovery and Precision Medicine
por: Huang, Zunnan, et al.
Publicado: (2021)

Editorial: Protein–Protein Interactions: Drug Discovery for the Future
por: Rapposelli, Simona, et al.
Publicado: (2021)

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Editorial: Computational Drug Discovery for Targeting of Protein-Protein Interfaces
por: Meli, Massimiliano, et al.
Publicado: (2021)

Editorial: Application of PROTACs as a Novel Strategy for Drug Discovery
por: Ibrahim, Hany S., et al.
Publicado: (2021)

Editorial: Cheminformatics Approaches in Drug Discovery for Neglected Tropical Diseases
por: Scotti, Luciana, et al.
Publicado: (2021)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Editorial: Computer-aided drug design: Drug discovery, computational modelling, and artificial intelligence
por: Ye, Fei, et al.
Publicado: (2022)

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
por: Pachón-Angona, Irene, et al.
Publicado: (2019)

Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents
por: Gouleni, Niki, et al.
Publicado: (2023)

Editorial: Advanced Silica Nanomaterials for Drug Delivery
por: Liu, Xijian, et al.
Publicado: (2021)

Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II
por: Morra, Giulia, et al.
Publicado: (2023)

Recent Research Progress: Discovery of Anti-Plant Virus Agents Based on Natural Scaffold
por: Chen, Jixiang, et al.
Publicado: (2022)

Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer’s disease therapy
por: Dgachi, Youssef, et al.
Publicado: (2018)

Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery
por: Kumar, Ashutosh, et al.
Publicado: (2018)

Editorial: Advances in Analytical Methods for Drugs of Abuse Testing
por: Fu, Shanlin, et al.
Publicado: (2019)

Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis
por: Rivera, Gildardo, et al.
Publicado: (2021)

Recent Advances Toward the Discovery of Drug-Like Peptides De novo
por: Goldflam, Michael, et al.
Publicado: (2015)

Discovery of quinolone derivatives as antimycobacterial agents
por: Liu, Kun-Lin, et al.
Publicado: (2021)

Ligand-based pharmacophore model for the discovery of novel CXCR2 antagonists as anti-cancer metastatic agents
por: Che, Jinxin, et al.
Publicado: (2018)

Autonomous intelligent agents for accelerated materials discovery
por: Montoya, Joseph H., et al.
Publicado: (2020)

Synthesis and Biological Evaluation of Benzochromenopyrimidinones as Cholinesterase Inhibitors and Potent Antioxidant, Non-Hepatotoxic Agents for Alzheimer’s Disease
por: Dgachi, Youssef, et al.
Publicado: (2016)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery
por: Veale, Clinton G. L., et al.
Publicado: (2018)

Design, synthesis, biological evaluation and molecular docking study of novel pyridoxine–triazoles as anti-Alzheimer's agents
por: Pal, Tiyas, et al.
Publicado: (2020)

Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
por: Ma, Shitang, et al.
Publicado: (2022)

Editorial: Advances in Tribochemistry
por: Chen, Lei, et al.
Publicado: (2022)

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
por: Alcaro, Stefano, et al.
Publicado: (2019)

Anti-obesity drug discovery: advances and challenges
por: Müller, Timo D., et al.
Publicado: (2021)

Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021
por: de Oliveira, Ramon G., et al.
Publicado: (2021)

Biomimetic synthesis of the natural product salviadione and its hybrids: discovery of tissue-specific anti-inflammatory agents for acute lung injury
por: Ding, Chunyong, et al.
Publicado: (2019)

Editorial: Advances in Oscillating Reactions
por: Cupić, Željko D., et al.
Publicado: (2021)

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020
por: Kareem, Rzgar Tawfeeq, et al.
Publicado: (2021)

Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review
por: Tella, Josephine Oluwagbemisola, et al.
Publicado: (2022)

Editorial: Discovery of Novel Molecules for Corrosion Protection Using Computational Chemistry
por: Obot, Ime B., et al.
Publicado: (2018)

Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer’s Disease Therapy
por: Zribi, Lazhar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rh89o0hpvcmbost7n6n57m61s4